Pre-Eclampsia Clinical Trial
Official title:
Evaluation of Intracranial Pressure With Optic Nerve Sheath Diameter Measurement in Women With or Without Preeclampsia
| NCT number | NCT04004897 |
| Other study ID # | Huseyin3 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | July 5, 2019 |
| Est. completion date | November 25, 2019 |
| Verified date | February 2020 |
| Source | Kanuni Sultan Suleyman Training and Research Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Severe preeclampsia is associated with an elevation in intracranial pressure (ICP). Optic nerve sheath diameter is a non-invasive surrogate of invasive ICP measurement. This study targets to evaluate the ICP in patients with or without preeclampsia.
| Status | Completed |
| Enrollment | 90 |
| Est. completion date | November 25, 2019 |
| Est. primary completion date | November 20, 2019 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years to 49 Years |
| Eligibility |
Inclusion Criteria: - Must be diagnosed as preeclampsia - Age must be > 18 years Exclusion Criteria: - History of previous intracranial pathology or surgery - Glaucoma |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Kanuni Sultan Suleyman Training and Research Hospital | Istanbul | Please Enter The State Or Province |
| Lead Sponsor | Collaborator |
|---|---|
| Kanuni Sultan Suleyman Training and Research Hospital |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | ICP | The difference in ICP estimated with optic nerve sheath diameter measurement among women with or without preeclampsia | At 6th hour of admission |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03299777 -
Correlation Between Changes in Liver Stiffness and Preeclampsia as Shown by Fibroscan
|
N/A | |
| Completed |
NCT03650790 -
C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese Pregnancies
|
N/A | |
| Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
| Not yet recruiting |
NCT03302260 -
Identifying Methods for Postpartum Reduction of Vascular Events: Pilot Randomized Controlled Trial
|
N/A | |
| Completed |
NCT02911701 -
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
|
Phase 4 | |
| Completed |
NCT01911494 -
Community Level Interventions for Pre-eclampsia
|
N/A | |
| Terminated |
NCT02025426 -
Phenylephrine Versus Ephedrine in Pre-eclampsia
|
Phase 4 | |
| Completed |
NCT01352234 -
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
|
Phase 4 | |
| Active, not recruiting |
NCT02031393 -
Establishing First Trimester Markers for the Identification of High Risk Twin
|
N/A | |
| Terminated |
NCT00141310 -
Sildenafil Citrate for the Treatment of Established Pre-Eclampsia
|
Phase 2 | |
| Completed |
NCT00157521 -
L-Arginine in Pre-Eclampsia
|
Phase 3 | |
| Completed |
NCT04795154 -
Prenatal Yoga as Complementary Therapy of Preeclampsia
|
N/A | |
| Completed |
NCT00004399 -
Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia
|
N/A | |
| Completed |
NCT00005207 -
Renin and Prorenin in Pregnancy
|
N/A | |
| Recruiting |
NCT04551807 -
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
|
Phase 3 | |
| Terminated |
NCT04092829 -
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
|
N/A | |
| Recruiting |
NCT06067906 -
Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients
|
N/A | |
| Recruiting |
NCT06317467 -
Role of Anti-C1q Autoantibodies in Pregnancy
|
||
| Completed |
NCT02218931 -
ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes
|
N/A | |
| Active, not recruiting |
NCT04484766 -
Preeclampsia Associated Vascular Aging
|